Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BTT Medical Institute is a clinical treatment center using FDA-cleared, noninvasive, brain-guided hyperthermia/hypothermia technology (CBIT 2) to induce therapeutic fever cycles and heat shock proteins in the brain for neurological and oncological conditions; published evidence currently consists of case-level data, including a reported complete reversal of amyotrophic lateral sclerosis in a single patient, with formal clinical trials planned to start in 2026.[2][3][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BTT Medical Institute.